Report Detail
Global (United States, European Union and China) Anti-Tumor Drugs Market Research Report 2019-2025
- RnM3648221 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It has been observed that cancer is second leading cause of deaths in Europe and North America. To treat these tumor growth, anti tumor drugs are considered as of one of the key therapy which has been accepted worldwide.
The market is concentrated in the North American region and together with Europe accounts for over 60% of the market share. The Asian and African economies possess a substantial growth opportunity owing to high cancer mortalities and bleak availability of effective drugs. Chinese and Japanese drug manufacturers dominate the Asian market with over 60% of the regional share.
In 2019, the market size of Anti-Tumor Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Tumor Drugs.
This report studies the global market size of Anti-Tumor Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-Tumor Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Roche
Novartis
Celgene
...
Market Segment by Product Type
Surgical
Chemotherapy
Radiation
Targeted
Immunotherapy
Market Segment by Application
Hospital Use
Clinic Use
Household
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anti-Tumor Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Tumor Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti-Tumor Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Anti-Tumor Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Surgical
- 1.3.3 Chemotherapy
- 1.3.4 Radiation
- 1.3.5 Targeted
- 1.3.6 Immunotherapy
- 1.4 Market Segment by Application
- 1.4.1 Global Anti-Tumor Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospital Use
- 1.4.3 Clinic Use
- 1.4.4 Household
- 1.4.5 Other
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Anti-Tumor Drugs Market Size
- 2.1.1 Global Anti-Tumor Drugs Revenue 2014-2025
- 2.1.2 Global Anti-Tumor Drugs Sales 2014-2025
- 2.2 Anti-Tumor Drugs Growth Rate by Regions
- 2.2.1 Global Anti-Tumor Drugs Sales by Regions 2014-2019
- 2.2.2 Global Anti-Tumor Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Anti-Tumor Drugs Sales by Manufacturers
- 3.1.1 Anti-Tumor Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Anti-Tumor Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Anti-Tumor Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Anti-Tumor Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Anti-Tumor Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Anti-Tumor Drugs Price by Manufacturers
- 3.4 Key Manufacturers Anti-Tumor Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Anti-Tumor Drugs Market
- 3.6 Key Manufacturers Anti-Tumor Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Surgical Sales and Revenue (2014-2019)
- 4.1.2 Chemotherapy Sales and Revenue (2014-2019)
- 4.1.3 Radiation Sales and Revenue (2014-2019)
- 4.1.4 Targeted Sales and Revenue (2014-2019)
- 4.1.5 Immunotherapy Sales and Revenue (2014-2019)
- 4.2 Global Anti-Tumor Drugs Sales Market Share by Type
- 4.3 Global Anti-Tumor Drugs Revenue Market Share by Type
- 4.4 Anti-Tumor Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Anti-Tumor Drugs Sales by Application
6 United States
- 6.1 United States Anti-Tumor Drugs Breakdown Data by Company
- 6.2 United States Anti-Tumor Drugs Breakdown Data by Type
- 6.3 United States Anti-Tumor Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Anti-Tumor Drugs Breakdown Data by Company
- 7.2 European Union Anti-Tumor Drugs Breakdown Data by Type
- 7.3 European Union Anti-Tumor Drugs Breakdown Data by Application
8 China
- 8.1 China Anti-Tumor Drugs Breakdown Data by Company
- 8.2 China Anti-Tumor Drugs Breakdown Data by Type
- 8.3 China Anti-Tumor Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Anti-Tumor Drugs Breakdown Data by Company
- 9.2 Rest of World Anti-Tumor Drugs Breakdown Data by Type
- 9.3 Rest of World Anti-Tumor Drugs Breakdown Data by Application
- 9.4 Rest of World Anti-Tumor Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Anti-Tumor Drugs Sales by Countries
- 9.4.2 Rest of World Anti-Tumor Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Roche
- 10.1.1 Roche Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Anti-Tumor Drugs
- 10.1.4 Anti-Tumor Drugs Product Introduction
- 10.1.5 Roche Recent Development
- 10.2 Novartis
- 10.2.1 Novartis Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Anti-Tumor Drugs
- 10.2.4 Anti-Tumor Drugs Product Introduction
- 10.2.5 Novartis Recent Development
- 10.3 Celgene
- 10.3.1 Celgene Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Anti-Tumor Drugs
- 10.3.4 Anti-Tumor Drugs Product Introduction
- 10.3.5 Celgene Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Anti-Tumor Drugs Sales Channels
- 11.2.2 Anti-Tumor Drugs Distributors
- 11.3 Anti-Tumor Drugs Customers
12 Market Forecast
- 12.1 Global Anti-Tumor Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Anti-Tumor Drugs Sales Forecast by Type
- 12.3 Global Anti-Tumor Drugs Sales Forecast by Application
- 12.4 Anti-Tumor Drugs Forecast by Regions
- 12.4.1 Global Anti-Tumor Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Anti-Tumor Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Anti-Tumor Drugs. Industry analysis & Market Report on Anti-Tumor Drugs is a syndicated market report, published as Global (United States, European Union and China) Anti-Tumor Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Anti-Tumor Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
